RD Health sees potential for greater penetration in the GLP-1 segment in 2027, says CEO
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The director-president of RD Saúde, Renato Raduan, said on Wednesday (4) see potential for greater participation in the market for weight-loss medicines in 2027. According to the executive, the goal is to compensate for the reduction in drug prices, generated by the popularization of options, with a growth in sales volume. Read more (11/04/2026